Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Saved in:
| Title: | Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial. |
|---|---|
| Authors: | Mileshkin LR; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia. Electronic address: linda.mileshkin@petermac.org., Moore KN; Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, USA., Barnes EH; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Gebski V; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Narayan K; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., King MT; School of Psychology, University of Sydney, Sydney, NSW, Australia., Bradshaw N; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Lee YC; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Diamante K; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Fyles AW; National Cancer Institute of Canada Clinical Trial Group, Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada., Small W Jr; Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, IL, USA., Gaffney DK; Department of Radiation Oncology, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA., Khaw P; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., Brooks S; Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand., Thompson JS; Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, USA., Huh WK; University of Alabama at Birmingham, Birmingham, AL, USA., Mathews CA; Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Brown University, Providence, RI, USA., Buck M; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Suder A; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Lad TE; Division of Hematology-Oncology, Cook County Hospital, Chicago, IL, USA., Barani IJ; Department of Radiation Oncology, St Joseph's Hospital and Medical Centre, Phoenix, AZ, USA., Holschneider CH; Division of Gynecologic Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Van Dyk S; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., Quinn M; Oncology Unit, Royal Women's Hospital and University of Melbourne, Melbourne, VIC, Australia., Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., Monk BJ; Division of Gynecologic Oncology, HonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ, USA., Stockler MR; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2023 May; Vol. 24 (5), pp. 468-482. Date of Electronic Publication: 2023 Apr 17. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37080223 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mileshkin+LR%22">Mileshkin LR</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia. Electronic address: linda.mileshkin@petermac.org.<br /><searchLink fieldCode="AU" term="%22Moore+KN%22">Moore KN</searchLink>; Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, USA.<br /><searchLink fieldCode="AU" term="%22Barnes+EH%22">Barnes EH</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Gebski+V%22">Gebski V</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Narayan+K%22">Narayan K</searchLink>; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22King+MT%22">King MT</searchLink>; School of Psychology, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Bradshaw+N%22">Bradshaw N</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+YC%22">Lee YC</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Diamante+K%22">Diamante K</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Fyles+AW%22">Fyles AW</searchLink>; National Cancer Institute of Canada Clinical Trial Group, Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Small+W+Jr%22">Small W Jr</searchLink>; Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, IL, USA.<br /><searchLink fieldCode="AU" term="%22Gaffney+DK%22">Gaffney DK</searchLink>; Department of Radiation Oncology, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Khaw+P%22">Khaw P</searchLink>; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Brooks+S%22">Brooks S</searchLink>; Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Thompson+JS%22">Thompson JS</searchLink>; Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, USA.<br /><searchLink fieldCode="AU" term="%22Huh+WK%22">Huh WK</searchLink>; University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Mathews+CA%22">Mathews CA</searchLink>; Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Brown University, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Buck+M%22">Buck M</searchLink>; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Suder+A%22">Suder A</searchLink>; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Lad+TE%22">Lad TE</searchLink>; Division of Hematology-Oncology, Cook County Hospital, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Barani+IJ%22">Barani IJ</searchLink>; Department of Radiation Oncology, St Joseph's Hospital and Medical Centre, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Holschneider+CH%22">Holschneider CH</searchLink>; Division of Gynecologic Oncology, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Dyk+S%22">Van Dyk S</searchLink>; Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Quinn+M%22">Quinn M</searchLink>; Oncology Unit, Royal Women's Hospital and University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Rischin+D%22">Rischin D</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Monk+BJ%22">Monk BJ</searchLink>; Division of Gynecologic Oncology, HonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Stockler+MR%22">Stockler MR</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2023 May; Vol. 24 (5), pp. 468-482. <i>Date of Electronic Publication: </i>2023 Apr 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37080223 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(23)00147-X Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 468 Titles: – TitleFull: Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mileshkin LR – PersonEntity: Name: NameFull: Moore KN – PersonEntity: Name: NameFull: Barnes EH – PersonEntity: Name: NameFull: Gebski V – PersonEntity: Name: NameFull: Narayan K – PersonEntity: Name: NameFull: King MT – PersonEntity: Name: NameFull: Bradshaw N – PersonEntity: Name: NameFull: Lee YC – PersonEntity: Name: NameFull: Diamante K – PersonEntity: Name: NameFull: Fyles AW – PersonEntity: Name: NameFull: Small W Jr – PersonEntity: Name: NameFull: Gaffney DK – PersonEntity: Name: NameFull: Khaw P – PersonEntity: Name: NameFull: Brooks S – PersonEntity: Name: NameFull: Thompson JS – PersonEntity: Name: NameFull: Huh WK – PersonEntity: Name: NameFull: Mathews CA – PersonEntity: Name: NameFull: Buck M – PersonEntity: Name: NameFull: Suder A – PersonEntity: Name: NameFull: Lad TE – PersonEntity: Name: NameFull: Barani IJ – PersonEntity: Name: NameFull: Holschneider CH – PersonEntity: Name: NameFull: Van Dyk S – PersonEntity: Name: NameFull: Quinn M – PersonEntity: Name: NameFull: Rischin D – PersonEntity: Name: NameFull: Monk BJ – PersonEntity: Name: NameFull: Stockler MR IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2023 May Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1474-5488 Numbering: – Type: volume Value: 24 – Type: issue Value: 5 Titles: – TitleFull: The Lancet. Oncology Type: main |
| ResultId | 1 |
